You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
5 August 2019
Bayer's Consumer Health division reported worldwide sales up by 2.1% on a currency- and portfolio-adjusted basis to EUR1.44 billion (USD1.61 billion). Werner Baumann, Bayer's chief executive officer, said the results demonstrated that Heiko Schipper and his team were "clearly making progress in turn...
22 July 2019
Private-equity firm Yellow Wood Partners is acquiring Bayer's Dr. Scholl's footcare business in the Americas for USD585 million.
1 July 2019
Alliance Pharma, Pfizer and the German Medicines Manufacturers' Association, the BAH, have all recently announced people changes.
14 May 2019
Beiersdorf is strengthening its position in the suncare category in North America by acquiring the Coppertone brand from Bayer Consumer Health for USD550 million.
26 April 2019
Bayer Consumer Health struggled in the first quarter of 2019, reporting worldwide sales down by 1.4% on a currency- and portfolio-adjusted basis to EUR1.40 billion (USD1.57 billion). Bayer's chief executive officer Werner Baumann said the business was expected to strengthen "gradually" in the coming...
4 March 2019
Bayer Consumer Health slipped back in the fourth quarter of 2018, reporting worldwide sales down by 1.7% on a currency- and portfolio-adjusted basis.
14 February 2019
Bayer Consumer Health has signed an exclusive European licensing agreement for MOB-015, Moberg Pharma's novel topical terbinafine formulation for treating nail fungus.
12 December 2018
Bayer says "accelerated innovation" and "a modernised marketing and sales strategy" will help its Consumer Health division achieve worldwide sales growth of 3%-4% by 2022.
29 November 2018
Bayer plans to "exit" the Coppertone and Dr. Scholl's brands, allowing it to focus on "driving profitable growth in its core Consumer Health categories".
14 November 2018
Bayer Consumer Health returned to growth in the third quarter of 2018, reporting worldwide sales up by 3.0% on a currency- and portfolio-adjusted basis. However, Bayer's chief executive officer Werner Baumann said the company's 2018 forecast for the division "looks increasingly challenging" to deliv...